相关实验视频

Updated: Jul 26, 2026

Mass Production of Genetically Modified Aedes aegypti for Field Releases in Brazil
17:41

Mass Production of Genetically Modified Aedes aegypti for Field Releases in Brazil

Published on: January 4, 2014

25.6K

甲状腺耐药性在Aedes aegypti:全球遗传机制,以及有效的载体控制的建议

Jonathan Rene Hernandez1, Patricia Victoria Pietrantonio2

  • 1Department of Entomology, Texas A&M University, College Station, TX, 77843-2475, USA.

Parasites & vectors
|October 15, 2025
PubMed
概括

由抗击抵抗 (kdr) 突变驱动的Aedes aegypti蚊子中的甲状腺耐药性是一个日益增长的全球威胁. 了解这些遗传机制对于有效的载体控制和疾病预防至关重要.

关键词:
艾得斯埃吉普提病毒 (Aedes aegypti) 是一个在KDR突变中发生的突变.杀虫剂生物测试 杀虫剂生物测试杀虫剂耐药性机制的机制综合载体管理 集成载体管理蚊子控制策略 蚊子控制战略铁甲状腺耐药性 铁甲状腺耐药性阻力比率 阻力比率电压调节通道的通道

更多相关视频

Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to Mosquitoes09:32

Protocols for Testing the Toxicity of Novel Insecticidal Chemistries to Mosquitoes

Published on: February 13, 2019

16.3K
Preparing Irradiated and Marked Male Aedes aegypti Mosquitoes for Release in an Operational Sterile Insect Technique Program08:58

Preparing Irradiated and Marked Male Aedes aegypti Mosquitoes for Release in an Operational Sterile Insect Technique Program

Published on: March 12, 2021

4.3K

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...